Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PharmAbcine Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology 2022-04-26 20:00
ITRI Named a Double Winner at Edison Awards 2022 2022-04-25 18:15
WuXi AppTec Reports Record First-Quarter In 2022 2022-04-25 17:52
World Malaria Day: Fosun Pharma's Self-Developed Artemisinin Series Become Symbol of China's Innovative Medicines 2022-04-25 17:00
Huison Virgin DHA Helps Infant Formula Safety Regulation and Innovation Development 2022-04-25 16:09
Porton Advanced and Sinorda Biomedicine Enter Strategic Collaboration to Accelerate Cell Therapy Development for Solid Tumors 2022-04-25 11:59
Bon Natural Life Limited Adds New Multi-Functional Health Supplements to Product Line 2022-04-21 21:00
SoftBank Robotics Group Makes Strategic Equity Investment in Avalon SteriTech 2022-04-20 15:07
Samsung Biologics completes full acquisition of Samsung Bioepis 2022-04-20 14:45
FDA granted CMG901 Fast Track Designation for unresectable or metastatic gastric and gastroesophageal junction cancer which have relapsed and/or are refractory to approved therapies 2022-04-20 10:27
ImmVira enters clinical development in combination therapy of MVR-T3011 IT and MEK inhibitor in the U.S. 2022-04-20 08:00
Bridge Biotherapeutics Enters into an Exclusive License Agreement with Shaperon to Strengthen Its IPF Franchise 2022-04-19 09:19
GeneQuantum and AIMEDBIO Collaborate on a First-in-Class Antibody -Drug-Conjugate 2022-04-19 09:00
A Brainwave Technology from Hyundai Mobis Proven to Reduce Drowsiness and Inattentive Driving by Up to 1/3 2022-04-18 21:00
WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC 2022-04-15 09:03
Asieris Pharmaceuticals Announces 2021 Annual Report: Steady Progress in Core Product Pipeline and Progressive Implementation of the Integrated Diagnosis and Treatment Commercialization Strategy 2022-04-14 22:49
Gracell Biotechnologies' Abstract on GC012F, a BCMA/CD19 Dual-targeting CAR-T Cell Therapy, Accepted for Presentation at 2022 ASCO Annual Meeting 2022-04-14 20:30
Akeso Publishes Preclinical Results of PD-1/LAG-3 Bi-specific Antibody(AK129)at the American Association for Cancer Research (AACR) 2022 Annual Meeting 2022-04-14 15:39
Akeso Publishes Preclinical Results of PD-1/CD73 Bi-specific Antibody(AK131)at the American Association for Cancer Research (AACR) 2022 Annual Meeting 2022-04-14 15:05
Akeso Publishes Preclinical Results of TIGIT monoclonal antibody(AK127)at the American Association for Cancer Research (AACR) 2022 Annual Meeting 2022-04-14 14:54
1 82 83 84 85 86 222